TY - JOUR
T1 - Normalization of serum C1q after intravenous immunoglobulin infusions in hypogammaglobulinemia
T2 - Dependence upon methods of immunoglobulin preparation
AU - Cunningham-Rundles, C.
N1 - Funding Information:
’ Supported in part by grants from the U.S. Public Health Service, CA 19267 and Al 15809; by the American Cancer Society, Grant IM 245: and by the Zelda Radow Weintraub Cancer Fund.
PY - 1984/11
Y1 - 1984/11
N2 - Low levels of serum complement subcomponent C1q may accompany primary humoral immunodeficiency diseases such as sex-linked agammaglobulinemia, severe combined immunodeficiency, and common varied immunodeficiency. This selective depression of C1q is proportional to the degree of hypogammaglobulinemia, and is corrected in severe combined immunodeficiency by bone marrow transplantation or in hypogammaglobulinemia by immunoglobulin infusions, possibly because C1q is stabilized by IgG by reversible interactions which reduce extravascular degradation. In this study it is shown that a pH 4.0 treated intravenous γ-globulin (ivGG) and a reduced and alkylated ivGG can equally increase levels of serum IgG, but that only the pH 4.0 preparation can raise C1q levels into the normal range. These findings show that some of the methods used to produce immunoglobulins suitable for intravenous use may hinder the ability of these molecules to stabilize C1q. The clinical implications of this observation remain unclear.
AB - Low levels of serum complement subcomponent C1q may accompany primary humoral immunodeficiency diseases such as sex-linked agammaglobulinemia, severe combined immunodeficiency, and common varied immunodeficiency. This selective depression of C1q is proportional to the degree of hypogammaglobulinemia, and is corrected in severe combined immunodeficiency by bone marrow transplantation or in hypogammaglobulinemia by immunoglobulin infusions, possibly because C1q is stabilized by IgG by reversible interactions which reduce extravascular degradation. In this study it is shown that a pH 4.0 treated intravenous γ-globulin (ivGG) and a reduced and alkylated ivGG can equally increase levels of serum IgG, but that only the pH 4.0 preparation can raise C1q levels into the normal range. These findings show that some of the methods used to produce immunoglobulins suitable for intravenous use may hinder the ability of these molecules to stabilize C1q. The clinical implications of this observation remain unclear.
UR - http://www.scopus.com/inward/record.url?scp=0021720342&partnerID=8YFLogxK
U2 - 10.1016/0090-1229(84)90072-2
DO - 10.1016/0090-1229(84)90072-2
M3 - Article
C2 - 6207968
AN - SCOPUS:0021720342
SN - 0090-1229
VL - 33
SP - 176
EP - 181
JO - Clinical Immunology and Immunopathology
JF - Clinical Immunology and Immunopathology
IS - 2
ER -